BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14648744)

  • 1. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia (Br J Surg 2003; 90: 1120-1128).
    Barham CP; Alderson D
    Br J Surg; 2003 Dec; 90(12):1608. PubMed ID: 14648744
    [No Abstract]   [Full Text] [Related]  

  • 2. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia.
    Dresner SM; Griffin SM; Wayman J; Bennett MK; Hayes N; Raimes SA
    Br J Surg; 2003 Sep; 90(9):1120-8. PubMed ID: 12945080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA; Basu KK; de Caestecker JS
    Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.
    Souza RF
    Biochem Soc Trans; 2010 Apr; 38(2):348-52. PubMed ID: 20298181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats.
    Miyashita T; Ohta T; Fujimura T; Ninomiya I; Fushida S; Hattori T; Miwa K
    Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease and Barrett's esophagus.
    Bittinger M; Messmann H
    Endoscopy; 2007 Feb; 39(2):118-23. PubMed ID: 17327970
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett's esophagus in children].
    Varela A
    Acta Gastroenterol Latinoam; 1999; 29(3):139-40. PubMed ID: 10533662
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett's--what is the interplay?
    Sharma P
    Gut; 2005 Jun; 54(6):739-40. PubMed ID: 15888772
    [No Abstract]   [Full Text] [Related]  

  • 14. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology of metaplasia and dysplasia in Barrett's esophagus.
    Yerian L
    Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric fluid bile concentrations and risk of Barrett's esophagus.
    Nason KS; Farrow DC; Haigh G; Lee SP; Bronner MP; Rosen SN; Vaughan TL
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):304-7. PubMed ID: 17669852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is duodenogastroesophageal reflux impliated in Barrett's esophagus?
    Lehrer JK; Katz PO
    Am J Gastroenterol; 2002 Sep; 97(9):2463-4. PubMed ID: 12358274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.